Market Overview

Benzinga's Top Upgrades, Downgrades For July 7, 2020

Share:

Upgrades

  • UBS upgraded the stock for OGE Energy Corp (NYSE: OGE) from Neutral to Buy. In the first quarter, OGE Energy showed an EPS of $0.23, compared to $0.24 from the year-ago quarter. The stock has a 52-week-high of $46.43 and a 52-week-low of $23.00. OGE Energy's stock last closed at $30.50 per share.
  • Wedbush changed the rating for Unum Therapeutics Inc (NASDAQ: UMRX) from Neutral to Outperform. Unum Therapeutics earned ($0.20) in the first quarter, compared to ($0.39) in the year-ago quarter. The stock has a 52-week-high of $2.84 and a 52-week-low of $0.29. Unum Therapeutics's stock last closed at $2.20 per share.
  • Needham upgraded the stock for Ambarella Inc (NASDAQ: AMBA) from Underperform to Buy. For the first quarter, Ambarella had an EPS of $0.04, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of $73.59 and a 52-week-low of $36.02. Ambarella's stock last closed at $46.79 per share.
  • For ACADIA Pharmaceuticals Inc (NASDAQ: ACAD), Stifel upgraded the stock from Hold to Buy. In the first quarter, ACADIA Pharmaceuticals showed an EPS of ($0.57), compared to ($0.59) from the year-ago quarter. The stock has a 52-week-high of $53.80 and a 52-week-low of $21.56. ACADIA Pharmaceuticals's stock last closed at $53.69 per share.
  • Deutsche Bank upgraded the stock for Arthur J. Gallagher & Co (NYSE: AJG) from Hold to Buy. In the first quarter, Arthur J. Gallagher showed an EPS of $1.83, compared to $1.63 from the year-ago quarter. The stock has a 52-week-high of $109.46 and a 52-week-low of $65.09. Arthur J. Gallagher's stock last closed at $96.85 per share.
  • For Trex Co Inc (NYSE: TREX), Baird upgraded the stock from Neutral to Outperform. In the first quarter, Trex Co showed an EPS of $0.73, compared to $0.54 from the year-ago quarter. The stock has a 52-week-high of $132.84 and a 52-week-low of $56.22. Trex Co's stock last closed at $126.61 per share.
  • For Valmont Industries Inc (NYSE: VMI), Stifel upgraded the stock from Hold to Buy. For the first quarter, Valmont Industries had an EPS of $1.99, compared to year-ago quarter EPS of $1.84. The stock has a 52-week-high of $154.86 and a 52-week-low of $82.60. Valmont Industries's stock last closed at $113.83 per share.

 

Downgrades

  • Benchmark changed the rating for ACM Research Inc (NASDAQ: ACMR) from Buy to Hold. In the first quarter, ACM Research showed an EPS of $0.11, compared to $0.14 from the year-ago quarter. The stock has a 52-week-high of $83.80 and a 52-week-low of $12.51. ACM Research's stock last closed at $80.84 per share.
  • Guggenheim downgraded the stock for BELLUS Health Inc (NASDAQ: BLU) from Buy to Neutral. For the first quarter, BELLUS Health had an EPS of ($0.18), compared to year-ago quarter EPS of ($0.08). The stock has a 52-week-high of $12.03 and a 52-week-low of $2.52. BELLUS Health's stock last closed at $3.40 per share.
  • Ladenburg Thalmann downgraded the stock for Digital Turbine Inc (NASDAQ: APPS) from Buy to Neutral. Digital Turbine earned $0.05 in the fourth quarter, compared to $0.03 in the year-ago quarter. The stock has a 52-week-high of $13.96 and a 52-week-low of $3.48. Digital Turbine's stock last closed at $13.43 per share.
  • For Evolus Inc (NASDAQ: EOLS), Mizuho downgraded the stock from Buy to Neutral. Evolus earned ($0.59) in the first quarter, compared to ($0.83) in the year-ago quarter. The stock has a 52-week-high of $20.27 and a 52-week-low of $3.12. Evolus's stock last closed at $5.32 per share.
  • Guggenheim changed the rating for Illumina Inc (NASDAQ: ILMN) from Buy to Neutral. For the first quarter, Illumina had an EPS of $1.64, compared to year-ago quarter EPS of $1.60. The stock has a 52-week-high of $384.21 and a 52-week-low of $196.78. Illumina's stock last closed at $379.39 per share.
  • JP Morgan downgraded the stock for Cosan Ltd (NYSE: CZZ) from Overweight to Neutral. Cosan earned $0.66 in the first quarter. The stock has a 52-week-high of $23.70 and a 52-week-low of $8.56. Cosan's stock last closed at $17.81 per share.
  • For Dominion Energy Inc (NYSE: D), Mizuho downgraded the stock from Neutral to Underperform. For the first quarter, Dominion Energy had an EPS of $1.09, compared to year-ago quarter EPS of $1.10. The stock has a 52-week-high of $90.89 and a 52-week-low of $57.79. Dominion Energy's stock last closed at $73.59 per share.
  • JP Morgan downgraded the stock for Fortinet Inc (NASDAQ: FTNT) from Overweight to Neutral. In the first quarter, Fortinet showed an EPS of $0.60, compared to $0.46 from the year-ago quarter. The stock has a 52-week-high of $149.69 and a 52-week-low of $70.20. Fortinet's stock last closed at $139.70 per share.
  • Goldman Sachs downgraded the stock for Kinder Morgan Inc (NYSE: KMI) from Neutral to Sell. For the first quarter, Kinder Morgan had an EPS of $0.24, compared to year-ago quarter EPS of $0.25. The stock has a 52-week-high of $22.58 and a 52-week-low of $9.42. Kinder Morgan's stock last closed at $15.20 per share.
  • BMO Capital changed the rating for ObsEva SA (NASDAQ: OBSV) from Outperform to Market Perform. For the first quarter, ObsEva had an EPS of ($0.48), compared to year-ago quarter EPS of ($0.59). The stock has a 52-week-high of $11.28 and a 52-week-low of $1.63. ObsEva's stock last closed at $3.25 per share.
  • JP Morgan changed the rating for Moelis & Co (NYSE: MC) from Neutral to Underweight. In the first quarter, Moelis & Co showed an EPS of $0.27, compared to $0.27 from the year-ago quarter. The stock has a 52-week-high of $41.27 and a 52-week-low of $22.11. Moelis & Co's stock last closed at $31.45 per share.
  • For First Hawaiian Inc (NASDAQ: FHB), Wells Fargo downgraded the stock from Equal-Weight to Underweight. For the first quarter, First Hawaiian had an EPS of $0.30, compared to year-ago quarter EPS of $0.53. The stock has a 52-week-high of $31.25 and a 52-week-low of $13.55. First Hawaiian's stock last closed at $16.74 per share.
  • JMP Securities downgraded the stock for Vivint Solar Inc (NYSE: VSLR) from Market Outperform to Market Perform. In the first quarter, Vivint Solar showed an EPS of ($0.32), compared to ($0.22) from the year-ago quarter. The stock has a 52-week-high of $12.99 and a 52-week-low of $3.17. Vivint Solar's stock last closed at $10.63 per share.
  • For CommScope Holding Co Inc (NASDAQ: COMM), Raymond James downgraded the stock from Outperform to Market Perform. In the first quarter, CommScope Hldg Co showed an EPS of $0.12, compared to $0.48 from the year-ago quarter. The stock has a 52-week-high of $15.93 and a 52-week-low of $5.50. CommScope Hldg Co's stock last closed at $8.68 per share.

 

Initiations

  • With a rating of Buy, Deutsche Bank initiated coverage on The AZEK Co Inc (NYSE: AZEK). The price target is set at $35.00 for AZEK Co.
  • Cowen & Co. initiated coverage on Burning Rock Biotech Ltd (NASDAQ: BNR) with an Outperform rating.
  • Benchmark initiated coverage on Cinedigm Corp (NASDAQ: CIDM) with a Speculative Buy rating. The price target for Cinedigm is set at $3.50. Cinedigm earned ($0.08) in the fourth quarter, compared to ($0.17) in the year-ago quarter. The stock has a 52-week-high of $6.00 and a 52-week-low of $0.25. Cinedigm's stock last closed at $2.08 per share.
  • Wedbush initiated coverage on Generation Bio Co (NASDAQ: GBIO) with an Outperform rating. The price target for Generation Bio is set at $31.00.
  • With a rating of Buy, Seaport Global initiated coverage on Hexcel Corp (NYSE: HXL). The price target is set at $52.00 for Hexcel. Hexcel earned $0.64 in the first quarter, compared to $0.84 in the year-ago quarter. The stock has a 52-week-high of $87.00 and a 52-week-low of $24.54. Hexcel's stock last closed at $45.11 per share.
  • Credit Suisse initiated coverage on Kura Oncology Inc (NASDAQ: KURA) with an Outperform rating. The price target for Kura Oncology is set at $27.00. For the first quarter, Kura Oncology had an EPS of ($0.42), compared to year-ago quarter EPS of ($0.37). The stock has a 52-week-high of $21.42 and a 52-week-low of $6.35. Kura Oncology's stock last closed at $16.72 per share.
  • With a rating of Equal-Weight, Barclays initiated coverage on Pegasystems Inc (NASDAQ: PEGA). The price target is set at $112.00 for Pegasystems. Pegasystems earned $0.05 in the first quarter, compared to ($0.12) in the year-ago quarter. The stock has a 52-week-high of $107.19 and a 52-week-low of $38.01. Pegasystems's stock last closed at $102.50 per share.
  • Citic Securities initiated coverage on Plug Power Inc (NASDAQ: PLUG) with an Overweight rating. The price target for Plug Power is set at $10.69. In the first quarter, Plug Power showed an EPS of ($0.12), compared to ($0.15) from the year-ago quarter. The stock has a 52-week-high of $10.49 and a 52-week-low of $1.88. Plug Power's stock last closed at $9.98 per share.
  • With a rating of Overweight, Barclays initiated coverage on The AZEK Co Inc (NYSE: AZEK). The price target is set at $37.00 for AZEK Co.
  • Stephens & Co. initiated coverage on Cerner Corp (NASDAQ: CERN) with a Equal-Weight rating. The price target for Cerner is set at $75.00. For the first quarter, Cerner had an EPS of $0.71, compared to year-ago quarter EPS of $0.61. The stock has a 52-week-high of $80.90 and a 52-week-low of $53.08. Cerner's stock last closed at $70.93 per share.
  • JP Morgan initiated coverage on Generation Bio Co (NASDAQ: GBIO) with an Overweight rating. The price target for Generation Bio is set at $28.00.
  • Stephens & Co. initiated coverage on IQVIA Holdings Inc (NYSE: IQV) with a Equal-Weight rating. The price target for IQVIA Holdings is set at $150.00. IQVIA Holdings earned $1.50 in the first quarter, compared to $1.53 in the year-ago quarter. The stock has a 52-week-high of $169.14 and a 52-week-low of $81.79. IQVIA Holdings's stock last closed at $143.63 per share.
  • Stephens & Co. initiated coverage on Livongo Health Inc (NASDAQ: LVGO) with an Overweight rating. The price target for Livongo Health is set at $95.00. Livongo Health earned $0.03 in the first quarter. The stock has a 52-week-high of $82.50 and a 52-week-low of $15.12. Livongo Health's stock last closed at $77.63 per share.
  • With a rating of Sector Perform, RBC Capital initiated coverage on Nikola Corp (NASDAQ: NKLA). The price target is set at $46.00 for Nikola. The stock has a 52-week-high of $93.99 and a 52-week-low of $31.25. Nikola's stock last closed at $48.92 per share.
  • Stephens & Co. initiated coverage on Omnicell Inc (NASDAQ: OMCL) with an Overweight rating. The price target for Omnicell is set at $90.00. In the first quarter, Omnicell showed an EPS of $0.66, compared to $0.61 from the year-ago quarter. The stock has a 52-week-high of $94.85 and a 52-week-low of $54.24. Omnicell's stock last closed at $66.76 per share.
  • Piper Sandler initiated coverage on PayPal Holdings Inc (NASDAQ: PYPL) with an Overweight rating. The price target for PayPal Holdings is set at $210.00. PayPal Holdings earned $0.66 in the first quarter, compared to $0.78 in the year-ago quarter. The stock has a 52-week-high of $181.24 and a 52-week-low of $82.07. PayPal Holdings's stock last closed at $176.18 per share.
  • Piper Sandler initiated coverage on Square Inc (NYSE: SQ) with a Neutral rating. The price target for Square is set at $131.00. In the first quarter, Square showed an EPS of ($0.02), compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $128.36 and a 52-week-low of $32.33. Square's stock last closed at $118.96 per share.
  • Stephens & Co. initiated coverage on Veeva Systems Inc (NYSE: VEEV) with an Overweight rating. The price target for Veeva Systems is set at $290.00. In the first quarter, Veeva Systems showed an EPS of $0.66, compared to $0.50 from the year-ago quarter. The stock has a 52-week-high of $249.51 and a 52-week-low of $118.11. Veeva Systems's stock last closed at $245.50 per share.
  • JP Morgan initiated coverage on Theravance Biopharma Inc (NASDAQ: TBPH) with an Overweight rating. The price target for Theravance Biopharma is set at $29.00. In the first quarter, Theravance Biopharma showed an EPS of ($1.14), compared to ($1.32) from the year-ago quarter. The stock has a 52-week-high of $31.54 and a 52-week-low of $15.72. Theravance Biopharma's stock last closed at $19.94 per share.
  • With a rating of Equal-Weight, Barclays initiated coverage on Trex Co Inc (NYSE: TREX). The price target is set at $134.00 for Trex Co. In the first quarter, Trex Co showed an EPS of $0.73, compared to $0.54 from the year-ago quarter. The stock has a 52-week-high of $132.84 and a 52-week-low of $56.22. Trex Co's stock last closed at $126.61 per share.
  • Chardan Capital initiated coverage on 89bio Inc (NASDAQ: ETNB) with a Buy rating. The price target for 89bio is set at $58.00. 89bio earned ($0.76) in the first quarter, compared to ($7.26) in the year-ago quarter. The stock has a 52-week-high of $47.25 and a 52-week-low of $14.00. 89bio's stock last closed at $26.48 per share.
  • With a rating of Buy, Chardan Capital initiated coverage on Akero Therapeutics Inc (NASDAQ: AKRO). The price target is set at $79.00 for Akero Therapeutics. Interestingly, in the first quarter, Akero Therapeutics's EPS was ($0.42). The stock has a 52-week-high of $35.34 and a 52-week-low of $10.78. Akero Therapeutics's stock last closed at $34.96 per share.
  • With a rating of Buy, Chardan Capital initiated coverage on NGM Biopharmaceuticals Inc (NASDAQ: NGM). The price target is set at $40.00 for NGM Biopharmaceuticals. NGM Biopharmaceuticals earned ($0.28) in the first quarter, compared to ($1.21) in the year-ago quarter. The stock has a 52-week-high of $23.95 and a 52-week-low of $8.81. NGM Biopharmaceuticals's stock last closed at $19.01 per share.
 

Related Articles (ACAD + ACMR)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesPenny Stocks Upgrades Downgrades Initiation Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
PRTKHC Wainwright & Co.Maintains19.0
MCRBHC Wainwright & Co.Maintains41.0
EOLSHC Wainwright & Co.Maintains8.0
PRTSSmall Cap Consumer ResearchMaintains16.0
FIXXHC Wainwright & Co.Maintains30.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com